These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9174826

  • 1. Salvage intraperitoneal therapy of advanced epithelial ovarian cancer: impact of retroperitoneal nodal disease.
    Barakat RR, Fennelly D, Pizzuto F, Venkatraman ES, Brown C, Curtin JP.
    Eur J Gynaecol Oncol; 1997; 18(3):161-3. PubMed ID: 9174826
    [Abstract] [Full Text] [Related]

  • 2. Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer.
    Markman M, Reichman B, Hakes T, Rubin S, Jones W, Lewis JL, Barakat R, Curtin J, Almadrones L, Hoskins W.
    Gynecol Oncol; 1992 Dec; 47(3):353-7. PubMed ID: 1473749
    [Abstract] [Full Text] [Related]

  • 3. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB, Antoniolli SZ, Maffei N, Beltrami P, Bassetto MA, Curti P.
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [Abstract] [Full Text] [Related]

  • 4. Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer.
    Markman M, Reichman B, Hakes T, Rubin S, Lewis JL, Jones W, Barakat R, Curtin J, Almadrones L, Hoskins W.
    Gynecol Oncol; 1993 Jul; 50(1):100-4. PubMed ID: 8349150
    [Abstract] [Full Text] [Related]

  • 5. Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenctomy have similar survival to Stage I/II patients and superior survival to other Stage III patients.
    Onda T, Yoshikawa H, Yasugi T, Mishima M, Nakagawa S, Yamada M, Matsumoto K, Taketani Y.
    Cancer; 1998 Oct 15; 83(8):1555-60. PubMed ID: 9781949
    [Abstract] [Full Text] [Related]

  • 6. Response to salvage treatment in recurrent ovarian cancer treated initially with paclitaxel and platinum-based combination regimens.
    Roland PY, Barnes MN, Niwas S, Robertson MW, Alvarez R, Austin JM, Kilgore LC, Partridge EE.
    Gynecol Oncol; 1998 Feb 15; 68(2):178-82. PubMed ID: 9514799
    [Abstract] [Full Text] [Related]

  • 7. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.
    Forum (Genova); 2000 Feb 15; 10(4):323-32. PubMed ID: 11535983
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of survival after second-line intraperitoneal cisplatin-based chemotherapy for advanced ovarian cancer.
    Piver MS, Recio FO, Baker TR, Driscoll D.
    Cancer; 1994 Mar 15; 73(6):1693-8. PubMed ID: 7512437
    [Abstract] [Full Text] [Related]

  • 9. Lack of substantial five year disease-free survival by primary aggressive surgery and cisplatin-based chemotherapy or by salvage intraperitoneal cisplatin-based chemotherapy.
    Piver MS, Baker TR, Driscoll DL.
    Eur J Gynaecol Oncol; 1990 Mar 15; 11(4):243-50. PubMed ID: 2245807
    [No Abstract] [Full Text] [Related]

  • 10. Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer.
    Aziz Z, Zahid M, Ud Din Ahmed Z, Arshad T.
    Aust N Z J Med; 1998 Jun 15; 28(3):403-9. PubMed ID: 9673759
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Retroperitoneal lymph node recurrence of epithelial ovarian cancer: Prognostic factors and treatment outcome.
    Levy T, Migdan Z, Aleohin N, Ben-Shem, Peled O, Tal O, Elyashiv O.
    Gynecol Oncol; 2020 May 15; 157(2):392-397. PubMed ID: 32151375
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S, Yeap B, Vogl S, Carbone P.
    Cancer; 1996 Feb 15; 77(4):733-42. PubMed ID: 8616766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.